Cure My Disease

Don't miss your cure!

 Log in / Sign up

New balance test could pinpoint dizziness after concussion

NCT ID NCT06893029

Diagnosis Sponsor: Dominik Straumann Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether watching moving patterns (like a spinning disk or VR display) can help doctors objectively diagnose visually induced dizziness. Researchers will measure balance and symptoms in 240 people, including those with concussion-related dizziness, non-concussion dizziness, and healthy controls. The goal is to create a more accurate diagnostic tool for this common but hard-to-measure condition.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a more accurate, objective test for diagnosing visually induced dizziness, helping doctors better identify and treat the condition.
What could go wrong
This is an early diagnostic study, not a treatment trial. It may not find clear differences between groups, and results may not apply to all patients with dizziness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 240 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 60 years * Binocular vision * Recent concussion/mTBI within 4 weeks to 18 months post-injury for concussed patients * Diagnosis related to dizziness or VID within 4 weeks to 18 months for non-concussed dizzy patients (including vestibular migraine) * Signed ICF for included participants or signed general consent for retrospectively included patients if an ICF cannot be obtained. Exclusion Criteria: * BMI greater than 30 * Acute vestibular syndrome lasting at least 24 hours * Severe non-correctable visual impairment * Balance issues not dizziness-related, including: 1. Neurological conditions (e.g., migraine) 2. Orthopaedic conditions (e.g., lower extremity injury) 3. Infectious diseases 4. Other medical contexts * Dizziness attributed to prescribed drugs, substance abuse, or mental disorders * Cognitive impairments compromising task comprehension * Preceding history of traumatic brain injury in the last 12 months * History of severe traumatic brain injury with persisting impairments * Other potentially confounding problems (e.g., psychiatric disease) * Frequent episodes of rotatory vertigo

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Balance assessment are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Brain Concussion Brain Injuries, Traumatic disease Dizziness traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Balance assessment Concussion (diagnosis) Dizziness Traumatic brain injury

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    2 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • BrainCare Medical Group

    RECRUITING

    Zurich, Canton of Zurich, 8002, Switzerland

    Contact Email: •••••@•••••

  • University Hospital Zurich, Department of Neurology

    RECRUITING

    Zurich, Canton of Zurich, 8006, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.